University of Cincinnati Hospital

Cincinnati, Ohio 45267

2 studies enrolling now · 8 studies all time

What they study most

Anemia, Sickle Cell, BK Virus Infection, BK Virus Nephropathy, Depressive Disorder, Major, Drug Abuse, Hypertriglyceridemia, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Priapism, Subarachnoid Hemorrhage, Traumatic Brain Injury

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide — Completed
• Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis — Stopped early
• Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia — Completed
• Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence — Completed
• Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention — Completed
• Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments — Completed